Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide vs PEG-4000 for constipation in type 2 diabetes mellitus
ChiCTR2100043302Phase 4Recruiting
- Sponsor
- 988th Hospital of PLA Joint Logistics Support Force
- Start
- Mar 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of linaclotide in constipation (2 arms), sponsored by 988th Hospital of PLA Joint Logistics Support Force. Primary endpoint: Frequency of spontaneous defecation per week after treatment. Started Mar 2021; status: recruiting.
02
Drugs
linaclotide
03
Conditions
constipation
Beyond the preview
Go deeper on ChiCTR2100043302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043302.